Division of Infectious Disease & International Medicine
College of Medicine - Department of Internal Medicine

Jose A. Montero MD, FACP

Associate Professor of Medicine, Division of Infectious Disease & International Medicine
Chief of Medical Staff, Kindred Hospital, Tampa, Florida
Faculty Coordinator, CDC STD Faculty Expansion Program, University of South Florida Morsani College of Medicine
Biographical Sketch | Areas of Expertise | Current Research | Publications
Education
MD, University of South Florida College of Medicine
Residency, Internal Medicine, Duke University, Durham, North Carolina
Fellowship, Infectious Disease, University of South Florida College of Medicine
Contact Information
E-Mail: jmontero@tgh.org
Phone: (813) 844-4187
FAX: (813) 844-7605

Biographical Sketch

Dr. Jose Montero received his BS and MD degrees from the University of South Florida. He traveled to Duke University Medical Center for his Internal Medicine residency. Upon completion of his fellowship training in Infectious Diseases, he joined the faculty as Assistant Professor at the University of South Florida College of Medicine in 1998 and was promoted to Associate Professor in 2003.
 
Dr. Montero is board certified in both Internal Medicine and Infectious Diseases. During his training he has been decorated with an array of honors and awards including: The Florida Infectious Disease Society Award and Membership in Alpha Omega Alpha. Since his faculty appointment, Dr. Montero has been involved in many activities exemplifying his keen abilities both as a clinician and educator. He has served as the Faculty Coordinator of the CDC STD/HIV Faculty Expansion Program, he is actively involved in the Florida AIDS Education Training Center, the regional Florida STD/HIV Prevention Training Center, and the USF CHART-India program which expands HIV education to clinicians in India.
 
Dr. Montero currently serves as the Chairman of Infection Control as well as Pharmacy and Therapeutics at Kindred Hospital Central Tampa. In 2006, he began serving as the Medical Director of Kindred Hospital Central Tampa.  He is the Medical Director of the Vascular Access Team at Tampa General Hospital. In 2004, he was appointed to the President's Advisory Council on HIV/AIDS (PACHA) which is a group of individuals who advises the President of the United States in domestic and international HIV issues. He has published over a dozen manuscripts including peer-reviewed articles, book chapters, and presented abstracts at various national conferences. Dr. Montero serves as Principal Investigator and Co-Investigator on many HIV clinical trials.

Areas of Expertise

HIV, STD, and Nosocomial Infections  

Current Research

Sinnott JT, Montero JA. STD Training Development Grant. Pfizer, 1999. ($75,000). Renewed 2001.

Toney JF, Montero JA, Sinnott JT, Schmitt K. Florida STD/HIV Prevention Training Center (PTC) -- Region IV STD/HIV Prevention Training Center [Program Announcement 00031]. Centers for Disease Control and Prevention, 2000-2005.

Current Protocols (Principal Investigator):

A Multicenter, Randomized, Double-blind, Comparative Trial of Maraviroc + Darunavir/Ritonavir versus Emtricitabine/Tenofovir + Darunavir/Ritonavir for the Treatment of Antiretroviral-Naive HIV-Infected Patients with CCR5-Tropic HIV [A4001095]

A Phase III, Randomized, Double Blind, Placebo Controlled Trial of Pregabalin on Peripheral Neuropathic Pain Associated with HIV [A00812244]

A Phase 2B Multicenter, Randomized, Comparative Trial of UK-453,061 versus Etravirine in Combination with Darunavir/Ritonavir and Nucleotide/Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Antiretroviral Experienced HIV-1 Infected Subjects with Evidence of NNRTI Resistant HIV-1 [A5271022]

Pilot Study of Novel Combination of Maraviroc + Atazanavir/Ritonavir Vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Treatment Naïve HIV-Infected Patients With R5 HIV-1 [A4001078]

The HIV Virologic Outcomes of Different Interventions among HAART Experienced Patients with Two Consecutive Detectable Low-Level Viremias [Bristol-Myers Squibb Virology Fellows Research Program]

A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus A Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections [WSA-CS-008]

A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL 8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Invasive Aspergillus Species or Other Filamentus Fungi [WSA –CS-004]

Safety and Efficacy of an Initial Regimen of Atazanavir + Ritonavir + the Abacavir/Lamivudine Fixed-Dose Combination Tablet for 36 weeks followed by Simplification to Atazanavir with the Abacavir/Lamivudine Fixed-Dose Combination Tablet or Maintenance of the Initial Regimen for an Additional 48 weeks in Antiretroviral-Naïve HIV-1 Infected HLA-B*5701 Negative Subjects [EPZ108859]

A Randomized, Controlled, Open-Label Trial to Compare the Efficacy, Safety and Tolerability of TMC114/RTV versus LPV/RTV in Treatment-Experienced HIV-1 Infected Subjects [TMC114-C214]

A Phase II Randomized, Controlled, Partially Blinded Trial to investigate Dose-Response of TMC114/RTV in 3-Class-Experienced HIV-1 Infected Subjects [TMC114-C202]
 
A Study of the Safety, Tolerability and Immunogenicity of HIV-1 Gag DNA Formulated with CRL1005 Adjuvant, Followed by the Adenovirus Serotype 5 HIV-1 Gag Vaccine (Ad5 HIV-1 gag) in a Prime/Boost Regimen [Merck V520-011]

Centers for Disease Control and Prevention/DHHS STD Knowledge and Attitude Survey in Incoming PGY-1 Primary Care Residents

Publications

Pham T, Alrabaa S, Somboonwit C, Hung L, Montero J.  The HIV Virologic Outcomes of Different Interventions among Treatment-experienced Patients with 2 Consecutive Detectable Low-level Viremia.  Journal of International Association of Physicians in AIDS Care. 10(1); 54-56, 2011

Tran D, Maradia K, Montero J. Lemierre Syndrome: a Rare Disease Affecting Previously Healthy, Young Individuals.  Southern Medical Journal. 103; 1190, 2010

Montero JA.  Infections in Indwelling Medical Devices.  The Association for Professionals in Infection Control and Epidemiology (APIC), Infection Control and Applied Epidemiology Principles and Practice, 2009. (Textbook chapter)

Montero JA.  Travel Recommendations for the HIV-infected.  Florida/Caribbean AIDS Education and Training Center HIV Carelink. 10(9), 2009.

Montero JA, Gompf SG.  Hepatitis C and HIV co-infection.  Florida/Caribbean AIDS Education and Training Center HIV Carelink.  8(4), 2007.

Montero JA: Implants. The Association for Professionals in Infection Control and Epidemiology (APIC) Infection Control and Applied Epidemiology Principles and Practice, 2005. (Textbook chapter)

Nadler J, Montero J. HIV – A brief look back at testing and treatment progress. Business Briefing: Long-Term Healthcare 2004; Business Briefings Ltd. 38-39, ref pp1-3, 2004.

Larkin JA, Montero JA. Efficacy and safety of amphotericin B lipid complex in the treatment of patients with zygomycosis. Infections in Medicine. 20: 201-206, 2003.

Montero JA, Zaulyanov LL, Houston SH, Sinnott JT. Chancroid: an update. Infections in Medicine. 19: 174-178, 2002.

Montero JA, Bartels LJ, Herman B, Sinnott JT. Tuberculous Otitis: Images in Infectious Diseases. Infections in Medicine. 19: 72, 2002.

Montero JA, Sinnott JT, Holt DA, Lloyd C. Biliary crytosporidiosis: current concepts. Infections in Medicine. 18: 312-316, 2001.

Montero JA: Infections Associated with Implantable Prosthetic Devices. The Association for Professionals in Infection Control and Epidemiology (APIC) Infection Control and Applied Epidemiology Principles and Practice, 2000. (Textbook chapter)

Toney JF, Montero JA. Sexually transmitted diseases: where do we go from here? Infections in Medicine. 17: 92-100, 127, 2000.

Montero JA. Management of Respiratory Tract Infections, second edition (book review). Infections in Medicine. 17: 598, 2000.

Larkin JA, Montero J, Targino M, Powers A, Accurso C, Campbell M. Rothia dentocariosa endocarditis. Clinical Microbiology Newsletter. 23(2), 2000.

Tsambiras PE, Montero JA, Greene JN, Sandin R. Recurrent cellulitis with
group G streptococcus bacteremia in a cancer patient: a case report.  Cancer
Control.  5: 184-186, 1998.

Montero JA, Larkin JA, Houston SH, Toney J.  Examining the complex  relationship of human papillomavirus to cervical dysplasia and carcinoma.   Medscape Women’s Health. 2, 1997.  (electronic article)

Poulos J, Johnson S, Conrad P, Montero J, Vesely D.  Domed-shaped lesion on  chest radiograph: retroperitoneal abscess dissecting through the posterior chest
wall.  Southern Medical Journal.  87: 77-80, 1994.

Houston SH, Glossa JS, Fisher A, Montero J, Rushton TR, Sinnott JT. 
Immunization of the organ transplant recipient. Infect Dis News. 1993; 12:86-87.

Abstracts and Presentations:

Choe U, Nasr G, Shah M, Somboonwit C, Montero J, Chen R, Menezes L.  HIV Virologic Outcomes in Associated with Ritonavir-boosted Atazanavir and Concomitant Acid Suppressive Therapy.  49th Infectious Disease Society of America Conference, Boston, MA, October 2011

Kelkar D. Baluch A, Karlapalem C, Sandin R, Sams K, Sanderson R, Montero J, Greene J. Demographic and Microbiological Correlated in Post GI-procedure Carbapenemase Producing Klebsiella pneumoniae (KPC) Infections in Florida. 5th Decennial International Conference on Healthcare-Associated Infections, Atlanta, 2010

Montero J, Thompson P, Widen R, Sinnott J.  Discordance Between a Rapid Antigen Test and PCR for Detection of Influenza in the Current Setting of an Evolving Pandemic of Novel H1N1.  49th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 2009

Search Google Scholar for Publications by Dr. Montero

Dr. Montero's BioSketch

Dr. Montero's CV